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Dear Editor,
C
eliac disease (CD) is an autoimmune disease 
resulting  in  inflammatory  destruction  of 
small intestinal mucosa after the ingestion of gluten 
in  genetically  susceptible  individuals.  The  study  of 
Leonardi and La Rosa (1) tries to establish a possible link 
between hepatitis B virus (HBV) infection and celiac 
disease. This is really interesting because only few cases 
have been described so far in the literature. However, 
there are two controversial points to be discussed in more 
detail—the development of CD after HBV infection or 
after treatment of chronic hepatitis with interferon, and 
an inadequate response to hepatitis B immunization in 
patients with CD.
In  the  first  case,  several  triggers  developing  an 
immunologic  intolerance  to  gluten  in  susceptible 
patients have already been described including HBV 
infection, natural interferon released in response to 
infection or exogenous interferon used for treatment 
of viral hepatitis (2, 3). However, we cannot establish 
definitive conclusions about the relationship between 
these two entities—HBV and CD. For this reason, in 
this study (1), the authors think that it is not mandatory 
to check for specific CD antibodies before beginning 
the treatment or during the follow-up; but this is still 
a point for discussion and other studies have proposed 
that these antibodies should be checked (3).
In  the  second  case,  data  regarding  the  response 
to HBV vaccine in CD suggest that non-response to 
vaccine is higher in CD patients than in control subjects 
(67.5% vs 85.2%) (4). The majority of these studies 
included adult celiac patients; it has been shown that 
younger subjects have a better response. Apart from the 
age, this poor response has been particularly associated 
with  the  major  histocompatibility  complex  (HLA) 
DQ2,  DR3  and  DR7  which  are  closely  associated 
with CD as well. Another study (5), demonstrated a 
correlation between the disease activity (by measuring 
serum  titers  of  anti-transglutaminase)  and  the 
development of an antibody response to HBV vaccine. 
A gluten-free diet might have a primary role and these 
authors suggested that HLA DQ2 per se, was not a 
good indicator for poor response to HBV vaccine.
In conclusion, we think that checking for specific CD 
antibodies should be recommended before beginning of 
the treatment with interferon or during the follow-up, 
although it is not mandatory since it is still a controversial 
issue. Finally, gluten-free diet may ameliorate the immune 
response to HBV vaccine in celiac patients; assessment of 
this response should be routinely considered in children 
newly diagnosed with CD.
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